Menu
Recent reports from 46brooklyn, a nonprofit think tank, and IQVIA, a drug industry analytics firm, criticized the financial dynamics of 340B.

Two Reports Critique Financial Dynamics of 340B Program

William Newton, Associate Editor/Senior Writer 340B Report Views
The 340B program may increase medication costs for self-insured employers, a recent study from a pharmaceutical industry outsourcing and analytics [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Post Navigation

340B Hospitals’ Low-Income Prostate Cancer Patients Had Better Adherence

Maryland House Unanimously Passes 340B Contract Pharmacy Bill

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live